SLC5A2 and heart failure: Nevertheless, the available clinical and experimental data support a need for further focused clinical and experimental studies, particularly given the current interest in the impact of novel anti-diabetes agents (e.g. SGLT2 inhibitors) on both heart failure and CKD.